Exagen, Inc. (XGN)
3.67
+0.26
(+7.62%)
USD |
NASDAQ |
Feb 23, 12:53
Exagen Market Cap : 83.17M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| FONAR Corp. | 116.80M |
| Interpace Biosciences, Inc. | 51.24M |
| Thermo Fisher Scientific, Inc. | 192.80B |
| XWELL, Inc. | 2.018M |
| Hypha Labs, Inc. | 5.132M |
Market Cap Related Metrics
| PS Ratio | 1.169 |
| Price to Book Value | 4.586 |
| Price | 3.67 |
| Earnings Yield | -25.22% |